Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-02-19 | Mrs. Medha GuptaInsider | 13,33k | 13,15k | Derivative Exercise and Retained Stock | 0,99 | 79,33k | 20,20% |
| 2026-01-23 | Mrs. Medha GuptaInsider | 19,07k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,94 | 72,40k | 35,75% |
| 2026-01-23 | Prof. John A. KellumChief Medical Officer | 208,33k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 2,41M | 9,47% |
| 2026-01-23 | Mr. Christopher SetoCEO, Interim CFO & Director | 416,67k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 5,43M | 8,30% |
| 2026-01-22 | Prof. John A. KellumChief Medical Officer | 151,31k | 0,00 | Derivative Exercise and Retained Stock | - | 285,13k | 113,06% |
| 2026-01-22 | Prof. John A. KellumChief Medical Officer | -248,69k | 233,95k | Derivative Exercise and Sale | 0,94 | 285,13k | - |
| 2026-01-15 | Dr. Paul M. WalkerIndependent Chairman of the Board | 85,45k | 0,00 | Derivative Exercise and Retained Stock | - | 2,24M | 3,96% |
| 2026-01-15 | Mrs. Medha GuptaInsider | 39,33k | 0,00 | Derivative Exercise and Retained Stock | - | 66,00k | 147,50% |
| 2026-01-01 | Mrs. Medha GuptaInsider | 13,33k | 0,00 | Derivative Exercise and Retained Stock | - | 26,67k | 100,00% |
| 2025-09-18 | Prof. John A. KellumChief Medical Officer | 25,00k | 0,00 | Derivative Exercise and Retained Stock | - | 133,82k | 22,97% |
| 2025-09-12 | Dr. Paul M. WalkerIndependent Chairman of the Board | -70,00k | 86,37k | Verkauf | 1,23 | 2,16M | -3,14% |
| 2025-09-08 | Mrs. Medha GuptaInsider | -13,33k | 0,00 | Derivative Exercise and Sale | - | 13,33k | - |
| 2025-08-27 | Mr. Christopher SetoCEO, Interim CFO & Director | 62,89k | 28,66k | Derivative Exercise and Retained Stock | 0,46 | 1,23M | 5,40% |
| 2025-08-27 | Mr. Christopher SetoCEO, Interim CFO & Director | -137,11k | 0,00 | Derivative Exercise and Sale | 0,46 | 1,23M | - |
| 2025-08-22 | Mr. William StevensIndependent Director | 100,00k | 45,54k | Derivative Exercise and Retained Stock | 0,46 | 971,80k | 11,47% |
| 2025-08-19 | Dr. Paul M. WalkerIndependent Chairman of the Board | 400,00k | 181,94k | Derivative Exercise and Retained Stock | 0,45 | 2,23M | 21,87% |
| 2025-08-14 | Mrs. Medha GuptaInsider | 13,33k | 3,53k | Derivative Exercise and Retained Stock | 0,26 | 13,33k | - |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
